Balance Sheets - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 2,329,218	$ 12,710,762
Collaboration receivable		5,000,000
Prepaid expenses	759,292	1,094,229
Deferred financing costs	408,000
Other current assets	20,188	9,283,625
Total current assets	3,516,698	28,088,616
Property and equipment, net	214,578	114,112
Other assets:
Goodwill	7,647,267	7,647,267
Other non-current assets	245,683	406,956
Total assets	11,624,226	36,256,951
Current liabilities:
Accounts payable	3,813,280	1,405,734
Accrued expenses	3,657,394	2,428,193
Deferred collaboration funding, current	8,412,971	15,825,938
Other current liabilities	741,425	9,450,085
Original Term Loan payable, current, at fair value	2,326,630
Total current liabilities	18,951,700	29,109,950
Deferred collaboration funding, non-current		8,661,109
Original Term Loan payable, non-current, at fair value	3,240,601
Convertible note payable, at fair value	6,047,532
Other non-current liabilities	145,665	209,497
Total liabilities	28,385,498	37,980,556
Commitments and Contingencies (Note 8)
Stockholders’ (deficit) equity:
Preferred stock, $0.0001 par value; authorized 10,000,000 shares; none issued and outstanding
Common stock, $0.0001 par value; authorized 150,000,000 shares; 19,624,280 and 14,310,244 shares issued and outstanding at December 31, 2022 and 2021, respectively	1,962	1,431
Additional paid-in capital	123,984,035	112,784,918
Accumulated deficit	(140,747,269)	(114,509,954)
Total stockholders' deficit	(16,761,272)	(1,723,605)
Total liabilities and stockholders' deficit	$ 11,624,226	$ 36,256,951